P. Tajik MD PhD publications

foto

Publications MD PhD P. Tajik

Position
Other Academic Staff
Main activities
Research
Specialisation
Development and Evaluation of Biomarkers for Predicting Treatment Effects in Clinical Trials: Method
Focus of research

1. Developing methods for identification and evaluation of markers to guide treatment decisions

2. Identification and evaluation of markers for guiding treatments for ovarian cancer patients

 

2020

  • Zafarmand Mohammad H., Tajik Parvin, Spijker René, Agyemang Charles Gene-environment Interaction on the Risk of Type 2 Diabetes Among Ethnic Minority Populations Living in Europe and North America: A Systematic Review Current diabetes reviews 2020;16 (5):457-470 [PubMed]
  • van de Vrie Roelien Treatment selection in advanced ovarian cancer 2020. 242p. ISBN 9789402820171. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kenter Gemma G.; Co-supervisors: Lok Christine A. R., Tajik Parvin)
  • van de Vrie R., van Werkhoven E., Rutten M. J., Asseler J. D., van Meurs H. S., Werter D. E., Buist M. R., Zwinderman A. H., Lok C. A. R., Bossuyt P. M. M., Kenter G. G., Tajik P. Validation of a treatment-selection rule for patients with advanced stage ovarian cancer European journal of gynaecological oncology 2020;41 (6):1023-1030

2019

  • van Werkhoven Erik, Tajik Parvin, Bossuyt Patrick M. Always randomize as late as possible Gastric cancer 2019;22 (6):1308-1309 [PubMed]

2018

  • Tajik Parvin, Zafarmand Mohammad Hadi, Zwinderman Aeilko H., Mol Ben W., Bossuyt Patrick M. Development and evaluating multimarker models for guiding treatment decisions BMC medical informatics and decision making 2018;18 (1) [PubMed]
  • Kang Chaeryon, Janes Holly, Tajik Parvin, Groen Henk, Mol Ben, Koopmans Corine, Broekhuijsen Kim, Zwertbroek Eva, van Pampus Maria, Franssen Maureen Evaluation of biomarkers for treatment selection using individual participant data from multiple clinical trials Statistics in medicine 2018;37 (9):1439-1453 [PubMed]
  • Tajik Parvin, van de Vrie Roelien, Zafarmand Mohammad H., Coens Corneel, Buist Marrije R., Vergote Ignace, Bossuyt Patrick M. M., Kenter Gemma G. The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy International journal of gynecological cancer 2018;28 (3):453-458 [PubMed]

2017

  • van der Tuuk K., Tajik P., Koopmans C. M., van den Berg P. P., Mol B. W. J., van Pampus M. G., Groen H. Blood pressure patterns in women with gestational hypertension or mild preeclampsia at term European journal of obstetrics, gynecology, and reproductive biology 2017;210:360-365 [PubMed]
  • Tjon-Kon-Fat R. I., Tajik P., Zafarmand M. H., Bensdorp A. J., Bossuyt P. M. M., Oosterhuis G. J. E., van Golde R., Repping S., Lambers M. D. A., Slappendel E., Perquin D., Pelinck M. J., Gianotten J., Maas J. W. M., Eijkemans M. J. C., van der Veen F., Mol B. W., van Wely M. IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers Human reproduction (Oxford, England) 2017;32 (5):1028-1032 [PubMed]

2016

  • Tajik P., Monfrance M., van 't Hooft J., Liem S. M. S., Schuit E., Bloemenkamp K. W. M., Duvekot J. J., Nij Bijvank B., Franssen M. T. M., Oudijk M. A., Scheepers H. C. J., Sikkema J. M., Woiski M., Mol B. W. J., Bekedam D. J., Bossuyt P. M., Zafarmand M. H. A multivariable model to guide the decision for pessary placement to prevent preterm birth in women with a multiple pregnancy: a secondary analysis of the ProTWIN trial Ultrasound in obstetrics & gynecology 2016;48 (1):48-55 [PubMed]
  • Bernardes T. P., Broekhuijsen K., Koopmans C. M., Boers K. E., van Wyk L., Tajik P., van Pampus M. G., Scherjon S. A., Mol B. W., Franssen M. T., van den Berg P. P., Groen H. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials BJOG 2016;123 (9):1501-1508 [PubMed]
  • Bernardes T. P., Broekhuijsen K., Koopmans C. M., Boers K. E., van Wyk L., Tajik P., van Pampus M. G., Scherjon S. A., Mol B. W., Franssen M. T., van den Berg P. P., Groen H. Caesarean Section Rates and Adverse Neonatal Outcomes After Induction of Labour Versus Expectant Management in Women With an Unripe Cervix: A Secondary Analysis of the HYPITAT and DIGITAT Trials EDITORIAL COMMENT Obstetrical & gynecological survey 2016;71 (12):691-692
  • Tjon-Kon-Fat Raïssa I., Tajik Parvin, Custers Inge M., Bossuyt Patrick M. M., van der Veen Fulco, van Wely Madelon, Mol Ben W., Zafarmand Mohammad H. Can we identify subfertile couples that benefit from immediate in vitro fertilisation over intrauterine insemination? European journal of obstetrics, gynecology, and reproductive biology 2016;202:36-40 [PubMed]

2015

  • Tajik Parvin Markers to guide treatment decisions: Methods and applications in obstetrics and gynecology 2015. 196p. ISBN 9789462595750. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Bossuyt P. M. M., Mol B. W. J.)
  • Broekhuijsen Kim, Bernardes Thomas, van Baaren Gert-Jan, Tajik Parvin, Novikova Natalia, Thangaratinam Shakila, Boers Kim, Koopmans Corine M., Wallace Kedra, Shennan Andrew H., Langenveld Josje, Groen Henk, van den Berg Paul P., Mol Ben Willem J., Franssen Maureen T. M. Relevance of individual participant data meta-analysis for studies in obstetrics: delivery versus expectant monitoring for hypertensive disorders of pregnancy European journal of obstetrics, gynecology, and reproductive biology 2015;191:80-83 [PubMed]

2014

  • Tajik Parvin, Majdzadeh Reza Constructing pragmatic socioeconomic status assessment tools to address health equality challenges International journal of preventive medicine 2014;5 (1):46-51 [PubMed]
  • Sattarzadeh Roya, Tavoosi Anahita, Tajik Parvin Echocardiographic estimation of left ventricular filling pressures in patients with mitral valve stenosis CARDIOVASCULAR JOURNAL OF AFRICA 2014;25 (1):34-39 [PubMed]
  • Tajik P., van der Ham D. P., Zafarmand M. H., Hof M. H. P., Morris J., Franssen M. T. M., de Groot C. J. M., Duvekot J. J., Oudijk M. A., Willekes C., Bloemenkamp K. W. M., Porath M., Woiski M., Akerboom B. M., Sikkema J. M., Nij Bijvank B., Mulder A. L. M., Bossuyt P. M., Mol B. W. J. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials BJOG 2014;121 (10):1263-72; discussion 1273 [PubMed]
  • Tajik Parvin, van Wyk Linda, Boers Kim E., le Cessie Saskia, Zafarmand Mohammad Hadi, Roumen Frans, van der Post Joris A. M., Porath Martina, van Pampus Maria G., Spaanderdam Marc E. A., Kwee Anneke, Duvekot Johannes J., Bremer Henk A., Delemarre Friso M. C., Bloemenkamp Kitty W. M., de Groot Christianne J. M., Willekes Christine, van Lith Jan M. M., Bossuyt Patrick M., Mol Ben W. J., Scherjon Sicco A. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial European journal of obstetrics, gynecology, and reproductive biology 2014;172:20-25 [PubMed]

2013

  • Tajik Parvin, Oude Rengerink Katrien, Mol Ben Willem, Bossuyt Patrick M. SYNTAX score II Lancet 2013;381 (9881):1899 [PubMed]
  • Tajik Parvin, Zwinderman Aleiko H., Mol Ben W., Bossuyt Patrick M. Trial designs for personalizing cancer care: a systematic review and classification Clinical cancer research 2013;19 (17):4578-4588 [PubMed]
  • van Meurs Hannah S., Tajik Parvin, Hof Michel H. P., Vergote Ignace, Kenter Gemma G., Mol Ben Willem J., Buist Marrije R., Bossuyt Patrick M. Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial European journal of cancer (Oxford, England 2013;49 (15):3191-3201 [PubMed]

2012

  • Tajik Parvin, Meijer Rudy, Duivenvoorden Raphaël, Peters Sanne A. E., Kastelein John J., Visseren Frank J., Crouse John R., Palmer Mike K., Raichlen Joel S., Grobbee Diederick E., Bots Michiel L. Asymmetrical distribution of atherosclerosis in the carotid artery: identical patterns across age, race, and gender European journal of preventive cardiology 2012;19 (4):687-697 [PubMed]
  • Tajik P., Van Der Tuuk K., Koopmans C. M., Groen H., Van Pampus M. G., Van Der Berg P. P., Van Der Post J. A., Van Loon A. J., De Groot C. J.M., Kwee A., Huisjes A. J.M., Van Beek E., Papatsonis D. N.M., Bloemenkamp K. W., Van Unnik G. A., Porath M., Rijnders R. J., Stigter R. H., De Boer K., Scheepers H. C., Zwinderman A. H., Bossuyt P. M., Mol B. W. Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? an exploratory analysis of the HYPITAT trial: Editorial comment Obstetrical & gynecological survey 2012;67 (12):751-753
  • Tajik P., van der Tuuk K., Koopmans C. M., Groen H., van Pampus M. G., van der Berg P. P., van der Post J. A., van Loon A. J., de Groot C. J. M., Kwee A., Huisjes A. J. M., van Beek E., Papatsonis D. N. M., Bloemenkamp K. W., van Unnik G. A., Porath M., Rijnders R. J., Stigter R. H., de Boer K., Scheepers H. C., Zwinderman A. H., Bossuyt P. M., Mol B. W. Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trial BJOG 2012;119 (9):1123-1130 [PubMed]

2011

  • Tajik Parvin, Bossuyt Patrick M. Genomic markers to tailor treatments: waiting or initiating? Human genetics 2011;130 (1):15-18 [PubMed]
  • Tajik Parvin, Oude Rengerink Katrien, Ganzevoort Wessel, Zwinderman Aeilko H., Mol Ben Willem, Bossuyt Patrick M. Prediction of pre-eclampsia complications Lancet 2011;377 (9774):1313 [PubMed]
  • Tajik Parvin, Bossuyt Patrick M., Mol Ben Willem Using a simplified bishop score to predict vaginal delivery Obstetrics and gynecology 2011;118 (2 Part 1):360; author reply 360 [PubMed]